Health Canada15 Oct 2026
Aleve 200 mg caplets : Rappel de la vente en gros (erreur de distribution)
Health Canada published a recall notice for Aleve 200 mg caplets : Rappel de la vente en gros (erreur de distribution) on 15 Oct 2026. It is one of 326 notices of this kind from Health Canada since 2 Apr 2026 in AreaZine's record.
Recall
The recall notice
- Issued by
- Health Canada
- Issued
- 15 Oct 2026
- Recall type
- Health product recall
- Companies
- Bayer Inc. · 2920 Matheson Blvd. E · Mississauga, ON L4W 5R6
- Official source
- Health Canada: the notice at its source
The latest from Health CanadaEvery warning and recall in Canada
Source: Health Canada: the notice at its source. AreaZine rebuilds this page from the agency's record; the agency's page is the one to act on. Contains information licensed under the Open Government Licence – Canada.
The notice as issued
Issue: Customer-returned products were inadvertently reintroduced into saleable inventory and distributed to the wholesale level. What you should do What to do: Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada. Additional information Background Affected products: Brand Product Name Market Authorization Dosage Form Strength Lot Number Aleve Aleve DIN 02301733 Caplets 220 mg NAAEWF2 Issue
Source: Health Canada: the notice at its source. The text is the agency's, unedited. Contains information licensed under the Open Government Licence – Canada.